A Phase 1 Study to Investigate the Absorption, Metabolism and Excretion of [14C]SPD557 Following a Single Oral Dose in Healthy Male Subjects
Phase of Trial: Phase I
Latest Information Update: 20 Dec 2018
Price : $35 *
At a glance
- Drugs SPD 557 (Primary)
- Indications Diabetic gastroparesis; Gastro-oesophageal reflux; Gastroparesis; Heartburn
- Focus Pharmacokinetics
- Sponsors Shire-Movetis NV
- 01 Apr 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 13 Feb 2013 New trial record
- 01 Feb 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.